GH Research (GHRS) stock jumped 20% after-hours ahead of its Jan 5 update on Phase 3 depression program and FDA IND status on ...
Questions may be submitted (via chat function) during the live webinar or submitted in advance via email to [email protected]. A live webcast of the webinar will be available on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback